+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Smart Pills Market by Application, Target Area, Disease Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4656206
  • Report
  • September 2018
  • Region: Global
  • 228 Pages
  • Allied Analytics LLP
Smart Pills Market Overview:



The global smart pills market was valued at $257 million in 2017, and is expected to reach $650 million by 2025, registering a CAGR of 12.1% from 2018 to 2025. Smart pill is an ingestible capsule with miniaturized micro-electronics. Smart pill is designed to visualize the gastrointestinal tract, thus allowing for the diagnosis and observation of lesions and disease states or conditions. As the capsule travels through the digestive tract, the camera clicks thousands of pictures that are transmitted to a recorder worn by the patient on a belt around the waist. Smart pills are widely being used for the diagnosis of various gastrointestinal disorders such as Barrett’s Esophagus, Irritable Bowel Syndrome, GERD (Gastroesophageal reflux disease) and others. In addition, smart pills are also being used for targeted drug delivery and patient monitoring. Smart pills find applications in solving the problem of medication non-adherence and enables the doctor to track the medication consumption patterns of a patient.

The key factors driving the market growth include rise in prevalence of gastrointestinal disorders such as ulcers, Crohn’s disease, colon cancer and others, favorable reimbursement scenario across the globe, and the preference of a patient toward minimally invasive diagnostic procedures. In addition, benefits offered by the smart pills such as non-invasive diagnostic procedures, controlled/targeted drug delivery, and real-time patient monitoring boost the growth of the market. However, stringent governmental regulations regarding the use of smart pills and high cost associated with them are anticipated to hamper the market growth. On the contrary, technological advancements, such as microprocessors, micro-camera, micro-sensors, and others, are predicted to create lucrative opportunities in the future.

The global smart pills market is segmented based on application, target area, disease indication, end user, and region. Based on application, the market is divided into capsule endoscopy, drug delivery, and patient monitoring. Based on target area, the market is classified into esophagus, small intestine, large intestine, and stomach. Based on disease indication, it is classified into Barrett's esophagus, Crohn’s disease, small bowel tumor, celiac disease, colon cancer, and others. Based on end user, it is classified into hospital, diagnostic center, and research center. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Smart Pills Market:

  • The study provides an in-depth analysis of the smart pills market with the current trends and future estimations to elucidate the imminent investment pockets.

  • A comprehensive analysis of the factors that drive and restrict the market growth is provided.

  • A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

  • An extensive analysis of the key segments of the industry helps to understand the trends in the smart pills market globally.

  • Key players and their strategies are provided to understand the competitive outlook of the industry.



Smart Pills Key Market Segments:

By Application

  • Capsule Endoscopy

  • Drug Delivery

  • Patient Monitoring



By Target Area

  • Esophagus

  • Small Intestine

  • Large Intestine

  • Stomach



By Disease Indication

  • Esophageal Diseases

  • Small Bowel Diseases

  • Colon Diseases

  • Others



By End User

  • Hospital

  • Diagnostic Center

  • Research Institute



By Region

  • North America

  • U.S.

  • Canada

  • Mexico

  • Europe

  • UK

  • France

  • Germany

  • Italy

  • France

  • Russia

  • Rest of Europe

  • Asia-Pacific

  • Japan

  • China

  • India

  • South Korea

  • Taiwan

  • Australia

  • Rest of Asia-Pacific

  • LAMEA

  • Saudi Arabia

  • South Africa

  • Brazil

  • Turkey

  • Argentina

  • Rest of LAMEA



KEY MARKET PLAYERS

  • Proteus Digital Health

  • HQ, Inc.

  • CapsoVision, Inc.

  • Medtronic Plc.

  • Olympus Corporations

  • IntroMedic Co., Ltd

  • RF Co., Ltd

  • JINSHAN Science & Technology

  • Check Cap

  • Koninklijke Philips N.V



The other players in the value chain include (profiles not included in the report)

  • GE Healthcare

  • NOVARTIS AG

  • Fujifilm Holdings Corporation

  • Bio-Images Drug Delivery (BDD) Limited

  • Quotient Clinical Ltd.

  • Innovative Devices LLC

  • PENTAX Medical

Frequently Asked Questions about the Global Smart Pills Market

What is the estimated value of the Global Smart Pills Market?

The Global Smart Pills Market was estimated to be valued at $257.0 million in 2017.

What is the growth rate of the Global Smart Pills Market?

The growth rate of the Global Smart Pills Market is 12.3%, with an estimated value of $650.0 million by 2025.

What is the forecasted size of the Global Smart Pills Market?

The Global Smart Pills Market is estimated to be worth $650.0 million by 2025.
Note: Product cover images may vary from those shown

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.3. Porters five forces analysis
3.4. Market share analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rising prevalence of gastrointestinal disorders
3.5.1.2. Increase in the R&D investments in developing smart pills by manufacturers
3.5.2. Restraints
3.5.2.1. Lengthy timelines regarding approval of smart pills
3.5.2.2. Higher costs associated with the smart pills
3.5.3. Opportunity
3.5.3.1. Increase in the technological advancements pertaining to smart pills
CHAPTER 4: SMART PILLS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Capsule Endoscopy
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Drug Delivery
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Patient Monitoring
4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: SMART PILLS MARKET, BY TARGET AREA
5.1. Overview
5.1.1. Market size and forecast
5.2. Esophagus
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Stomach
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Small Intestine
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Large Intestine
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: SMART PILLS MARKET, BY DISEASE INDICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Esophagus Diseases
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Small Bowel Disease
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.3.2.1. Crohns Disease
6.3.2.1.1. Market size and forecast
6.3.2.2. Small bowel tumors
6.3.2.2.1. Market size and forecast
6.3.2.3. Celiac disease
6.3.2.3.1. Market size and forecast
6.3.2.4. Others
6.3.2.4.1. Market size and forecast
6.4. Colon Diseases
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: SMART PILLS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Diagnostic Centers
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Hospitals & Clinics
7.3.1. Market size and forecast
7.3.2. Market analysis, by country
7.4. Research Institutes
7.4.1. Market size and forecast
7.4.2. Market analysis, by country
CHAPTER 8: SMART PILLS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. North America market size & forecast, by country
8.2.2. North America market size & forecast, by application
8.2.3. North America market size & forecast, by target area
8.2.4. North America market size & forecast, by disease indication
8.2.5. North America market size & forecast, by end user
8.2.5.1. U.S. market size & forecast, by application
8.2.5.2. U.S. market size & forecast, by target area
8.2.5.3. U.S. market size & forecast, by disease indication
8.2.5.4. U.S. market size & forecast, by end user
8.2.5.5. Canada market size & forecast, by application
8.2.5.6. Canada market size & forecast, by target area
8.2.5.7. Canada market size & forecast, by disease indication
8.2.5.8. Canada market size & forecast, by end user
8.2.5.9. Mexico market size & forecast, by application
8.2.5.10. Mexico market size & forecast, by target area
8.2.5.11. Mexico market size & forecast, by disease indication
8.2.5.12. Mexico market size & forecast, by end user
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Europe market size & forecast for smart pills market, by country
8.3.3. Europe market size & forecast, by application
8.3.4. Europe market size & forecast, by target area
8.3.5. Europe market size & forecast, by disease indication
8.3.6. Europe market size & forecast, by end user
8.3.6.1. Germany market size & forecast, by application
8.3.6.2. Germany market size & forecast, by target area
8.3.6.3. Germany market size & forecast, by disease indication
8.3.6.4. Germany market size & forecast, by end user
8.3.6.5. France market size & forecast, by application
8.3.6.6. France market size & forecast, by target area
8.3.6.7. France market size & forecast, by disease indication
8.3.6.8. France market size & forecast, by end user
8.3.6.9. UK market size & forecast, by application
8.3.6.10. UK market size & forecast, by target area
8.3.6.11. UK market size & forecast, by disease indication
8.3.6.12. UK market size & forecast, by end user
8.3.6.13. Italy market size & forecast, by application
8.3.6.14. Italy market size & forecast, by target area
8.3.6.15. Italy market size & forecast, by disease indication
8.3.6.16. Italy market size & forecast, by end user
8.3.6.17. Spain market size & forecast, by application
8.3.6.18. Spain market size & forecast, by target area
8.3.6.19. Spain market size & forecast, by disease indication
8.3.6.20. Spain market size & forecast, by end user
8.3.6.21. Rest of Europe market size & forecast, by application
8.3.6.22. Rest of Europe market size & forecast, by target area
8.3.6.23. Rest of Europe market size & forecast, by disease indication
8.3.6.24. Rest of Europe market size & forecast, by end user
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size & forecast, by country
8.4.3. Asia-Pacific market size & forecast, by application
8.4.4. Asia-Pacific market size & forecast, by target area
8.4.5. Asia-Pacific market size & forecast, by disease indication
8.4.6. Asia-Pacific market size & forecast, by end user
8.4.6.1. India market size & forecast, by application
8.4.6.2. India market size & forecast, by target area
8.4.6.3. India market size & forecast, by disease indication
8.4.6.4. India market size & forecast, by end user
8.4.6.5. China market size & forecast, by application
8.4.6.6. China market size & forecast, by target area
8.4.6.7. China market size & forecast, by disease indication
8.4.6.8. China market size & forecast, by end user
8.4.6.9. Japan market size & forecast, by application
8.4.6.10. Japan market size & forecast, by target area
8.4.6.11. Japan market size & forecast, by disease indication
8.4.6.12. India market size & forecast, by end user
8.4.6.13. Australia market size & forecast, by application
8.4.6.14. Australia market size & forecast, by target area
8.4.6.15. Australia market size & forecast, by disease indication
8.4.6.16. Australia market size & forecast, by end user
8.4.6.17. Rest of Asia-Pacific market size & forecast, by application
8.4.6.18. Rest of Asia-Pacific market size & forecast, by Target Area
8.4.6.19. Rest of Asia-Pacific market size & forecast, by disease indication
8.4.6.20. Rest of Asia-Pacific market size & forecast, by end user
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. LAMEA market size & forecast, by country
8.5.3. LAMEA market size & forecast, by application
8.5.4. LAMEA market size & forecast, by target area
8.5.5. LAMEA market size & forecast, by disease indication
8.5.6. LAMEA market size & forecast, by end user
8.5.6.1. Brazil market size & forecast, by application
8.5.6.2. Brazil market size & forecast, by target area
8.5.6.3. Brazil market size & forecast, by disease indication
8.5.6.4. Brazil market size & forecast, by end user
8.5.6.5. South Africa market size & forecast, by application
8.5.6.6. South Africa market size & forecast, by target area
8.5.6.7. South Africa market size & forecast, by disease indication
8.5.6.8. South Africa market size & forecast, by end user
8.5.6.9. Saudi Arabia market size & forecast, by application
8.5.6.10. Saudi Arabia market size & forecast, by target area
8.5.6.11. Saudi Arabia market size & forecast, by disease indication
8.5.6.12. Saudi Arabia market size & forecast, by end user
8.5.6.13. Argentina market size & forecast, by application
8.5.6.14. Argentina market size & forecast, by target area
8.5.6.15. Argentina market size & forecast, by disease indication
8.5.6.16. Argentina market size & forecast, by end user
8.5.6.17. Rest of LAMEA market size & forecast, by application
8.5.6.18. Rest of LAMEA market size & forecast, by target area
8.5.6.19. Rest of LAMEA market size & forecast, by disease indication
8.5.6.20. Rest of LAMEA market size & forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. CapsoVision, Inc.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Key strategic moves and developments
9.2. Check-Cap Ltd.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.3. HQ.Inc.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.4. IntroMedic Co., Ltd
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. JINSHAN Science & Technology
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments
9.6. Koninklijke Philips N.V.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.7. Medtronic plc
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. OLYMPUS Corporation.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.9. Proteus Digital Health
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments
9.10. RF Co., Ltd.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
Note: Product cover images may vary from those shown
According to a new report titled, Smart Pills Market by Application, Target Area, Disease Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2017 - 2025, the global smart pills market was valued at $257 million in 2017, and is projected to reach $650 million by 2025, growing at a CAGR of 12.1% from 2018 to 2025. The capsule endoscopy segment accounted for more than half of the total market share in 2017.

Smart pills are capsule-sized ingestible medical devices that consist of micro-sensors, micro-cameras, patches, and trackers. Smart pills by making use of these micro-sensors and cameras help in more appropriate and non-invasive disease diagnostics. Smart pills, being non-invasive can be a potent alternative approach against invasive procedures such as gastrointestinal endoscopy/colonoscopy. The product has its wide application in drug delivery and real-time patient monitoring. It is an innovative approach to gather images from areas of the gastrointestinal tract, such as colon, where traditional endoscopies are unable to reach. Once swallowed, sensors provide information about various health parameters of the patient and the effectiveness of the medication treatment, which facilitate in taking informed healthcare decisions and optimized therapies.

Moreover, a significant rise in geriatric population, rise in chronic disorders such as cancer, diabetes, and others, drive the smart pills market growth. In addition, increased R&D investments by manufacturers in developing smart pills boosts the market growth. However, stringent governmental regulations regarding the vigorous use of these devices and high cost associated with the ingestible sensors is anticipated to restrain the market growth. On the contrary, surge in technological advances in bioelectronics, and availability of microprocessors are anticipated to offer lucrative opportunities in the future.

The capsule endoscopy segment generated the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the increase in use of capsule endoscopes for diagnosis of gastrointestinal disorders and surge in preferences for non-invasive procedures. In addition, the capsule endoscopy segment is expected to register the highest growth rate during the forecast period.

Key Findings of the Smart Pills Market Study:

The small intestine segment, by target area dominated the smart pills market in 2017 and is expected to maintain this trend during the forecast period.
The colon disease segment, by disease indication, is expected to register highest CAGR of 13.6% from 2018-2025.
U.S. generated the highest revenue in the global smart pills market in 2017 accounting for more than half of the market in North America.
Asia-Pacific is the fastest growing region in the smart pills market in 2017 and is anticipated to experience rapid growth during the forecast period.

North America was the leading revenue contributor to the global market in 2017, owing to the increase in healthcare investments by the government, surge in R&D expenditure for the development of smart pills, and technological advancements regarding diagnostic procedures. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase in healthcare facilities, surge in disposable income, and rise in awareness towards non-invasive diagnostic procedures.

The report provides an extensive competitive analysis and profiles of the key market players, such as Proteus Digital Health, HQ, Inc., CapsoVision, Inc., Medtronic Plc., Olympus Corporations, IntroMedic Co., Ltd, RF Co., Ltd, JINSHAN Science & Technology, Check Cap, and Koninklijke Philips N.V. The other players in the value chain (not included in the report) include GE Healthcare, NOVARTIS AG, Fujifilm Holdings Corporation, Bio-Images Drug Delivery (BDD) Limited, Quotient Clinical Ltd., Innovative Devices LLC, and PENTAX Medical.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...